OXLUMOHCP.COM: Keyword Density Checker

Total words: 2430 | 2-word phrases: 637 | 3-word phrases: 705 | 4-word phrases: 732

PAGE INFO

Title	Try to keep the title under 60 characters (54 characters) OXLUMO® (lumasiran) \| Healthcare Professional Website
Description	Try to keep the meta description between 50 - 160 characters (252 characters) OXLUMO® (lumasiran) is the first FDA‐approved medication for the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary and plasma oxalate levels in children and adults. See Important Safety Information on risk of injection site reactions.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	primary hyperoxaluria type 1	3	0.41%
2	hyperoxaluria type 1 ph1	3	0.41%
3	of primary hyperoxaluria type	3	0.41%
4	treatment of primary hyperoxaluria	3	0.41%
5	reduction in 24hr uox	2	0.27%
6	feature real patients in	2	0.27%
7	not be on an	2	0.27%
8	patients may or may	2	0.27%
9	advertising patients may or	2	0.27%
10	our advertising patients may	2	0.27%
11	in our advertising patients	2	0.27%
12	patients in our advertising	2	0.27%
13	real patients in our	2	0.27%
14	person with ph1 alnylam	2	0.27%
15	to feature real patients	2	0.27%
16	with ph1 alnylam is	2	0.27%
17	on an alnylam therapy	2	0.27%
18	× you are now	2	0.27%
19	for the treatment of	2	0.27%
20	the treatment of primary	2	0.27%
21	visit site cancel ×	2	0.27%
22	type 1 ph1 to	2	0.27%
23	levels in children and	2	0.27%
24	be on an alnylam	2	0.27%
25	proud to feature real	2	0.27%
26	in children and adults	2	0.27%
27	full prescribing information patient	2	0.27%
28	safety information full prescribing	2	0.27%
29	information full prescribing information	2	0.27%
30	prescribing information patient site	2	0.27%
31	202138412161226 doi101056nejmoa2021712 5 lieske	1	0.14%
32	its effects on breastfed	1	0.14%
33	information adverse reactions the	1	0.14%
34	boston ma important safety	1	0.14%
35	2022 boston ma important	1	0.14%
36	the presence of oxlumo	1	0.14%
37	presence of oxlumo in	1	0.14%
38	of oxlumo in human	1	0.14%
39	oxlumo in human milk	1	0.14%
40	in human milk or	1	0.14%

#	URL	Whois	Check
1	https://www.alnylam.com/oxlumo-us-prescribing-information	Whois	alnylam.com
2	https://www.oxlumo.com	Whois	oxlumo.com
3	https://www.alnylam.com/oxlumo-us-prescribing-information	Whois	alnylam.com
4	https://www.oxlumo.com	Whois	oxlumo.com
5	https://www.oxlumo.com	Whois	oxlumo.com
6	https://alnylamconnect.com/oxlumo	Whois	alnylamconnect.com
7	https://alnylamconnect.com/oxlumo	Whois	alnylamconnect.com
8	https://www.alnylam.com/oxlumo-us-prescribing-information	Whois	alnylam.com
9	https://www.oxlumo.com/	Whois	oxlumo.com
10	https://www.alnylam.com	Whois	alnylam.com
11	https://alnylampolicies.com/privacy	Whois	alnylampolicies.com
12	https://alnylampolicies.com/legal	Whois	alnylampolicies.com
13	https://www.alnylam.com/contact-us/	Whois	alnylam.com